These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37243682)

  • 1. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review.
    Prezioso G; Chiarelli F; Matricardi S
    Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
    Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
    Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epileptic spasms in tuberous sclerosis complex.
    Hsieh DT; Jennesson MM; Thiele EA
    Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
    Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY;
    Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
    Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
    Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin - new data on indications and safety in paediatric epilepsy.
    Golec W; Sołowiej E; Strzelecka J; Jurkiewicz E; Jóźwiak S
    Neurol Neurochir Pol; 2021; 55(5):429-439. PubMed ID: 34541635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
    Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
    Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of vigabatrin in west syndrome associated with tuberous sclerosis].
    Ando N; Fujimoto S; Ishikawa T; Kobayashi S; Hattori A; Ito T; Togari H
    No To Hattatsu; 2010 Nov; 42(6):444-8. PubMed ID: 21077355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin for tuberous sclerosis complex.
    Curatolo P; Verdecchia M; Bombardieri R
    Brain Dev; 2001 Nov; 23(7):649-53. PubMed ID: 11701271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
    van der Poest Clement EA; Sahin M; Peters JM
    J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
    Hancock E; Osborne JP
    J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
    Yum MS; Lee EH; Ko TS
    J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
    Friedman D; Bogner M; Parker-Menzer K; Devinsky O
    Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life data comparing the efficacy of vigabatrin and oral steroids given sequentially or combined for infantile epileptic spasms syndrome.
    Dozieres-Puyravel B; Nasser H; Mauvais FX; De Saint Martin A; Perriard C; Di Meglio C; Cances C; Hachon-LE Camus C; Milh M; Auvin S
    Eur J Paediatr Neurol; 2024 Jan; 48():61-66. PubMed ID: 38041897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis.
    Chiron C; Dumas C; Jambaqué I; Mumford J; Dulac O
    Epilepsy Res; 1997 Jan; 26(2):389-95. PubMed ID: 9095401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin: 2008 update.
    Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
    Iyer A; Appleton R
    Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.